4//SEC Filing
GOLDFISCHER CARL 4
Accession 0000899243-21-023866
CIK 0001571498other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:35 PM ET
Size
9.2 KB
Accession
0000899243-21-023866
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
GOLDFISCHER CARL
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-06-11+40,559→ 40,559 totalExercise: $8.53Exp: 2031-06-10→ Common Stock (40,559 underlying) - Award
Common Stock, par value $0.0001
2021-06-11+8,060→ 13,060 total
Holdings
- 3,380,951(indirect: See Footnote)
Common Stock, par value $0.0001
Footnotes (3)
- [F1]Consists of shares of Common Stock issuable under 8,060 restricted stock units ("RSUs") granted on June 11, 2021, which RSUs are scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. Each RSU represents the right to receive one share of Common Stock upon vesting. In the event of a change in control of the Issuer, the RSUs will vest in full.
- [F2]Represents shares of common stock held by entities affiliated with Bay City Capital, LLC including Bay City Capital Fund V, L.P. and Bay City Capital Fund V Co-Investment Fund, L.P. Bay City Capital Management V LLC ("GP V") is the general partner of Bay City Capital Fund V, L.P. and Bay City Capital Fund V Co-Investment Fund, L.P. (collectively, "BCC V"). Bay City Capital, LLC ("BCC LLC") is the manager of GP V. The Reporting Person is an investment partner and managing director of BCC LLC and shares voting and dispositive power with respect to shares held by BCC V. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
- [F3]This option was granted on June 11, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeother
Related Parties
1- filerCIK 0001110780
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:35 PM ET
- Size
- 9.2 KB